FIELD: biotechnology, veterinary mycology. SUBSTANCE: vaccine has a mixture of antigens from culture fungus Trichophyton verrucosum VIEV N 478 and Trichophyton verrucosum VIEV N 145 taken at equal ratios at concentration 60-160 mln microconidia/1 ml 4-5% NaCl solution in the presence of aluminium hydroxide as an adjuvant. EFFECT: enhanced effectiveness of vaccine.
Authors
Dates
1997-10-20—Published
1995-03-16—Filed